Institution statistics

ASTELLAS PHARMA EUROPE BV - NL 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 8.728.185 0 1
2019 0 8.000.000 0 1
2018 0 7.750.000 0 2
2016 0 21.085.937 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV4
BAYER3
ELI LILLY AND COMPANY LIMITED3
EUROPEAN CANCER PATIENT COALITION3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AMGEN LIMITED2
ASTRAZENECA AB2
BAYER PHARMA2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ERASMUS UNIVERSITEIT ROTTERDAM2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS2
KATHOLIEKE UNIVERSITEIT LEUVEN2
LUNDS UNIVERSITET2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NOVARTIS PHARMA2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITY OF TAMPERE2
ABBVIE1
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACTELION PHARMACEUTICALS1
AMGEN RESEARCH1
ASSOCIATION EISBM1
ASTRAZENECA1
BAYER AKTIENGESELLSCHAFT1
BIOSCI CONSULTING BVBA1
BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CANCER INTELLIGENCE LIMITED1
CELGENE MANAGEMENT SARL1
CHU HOPITAUX DE BORDEAUX1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
COVANCE LABORATORIES1
CSL BEHRING1
DRESDEN UNIVERSITY OF TECHNOLOGY1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN PATIENTS' FORUM1
F HOFFMANNLA ROCHE1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
GOETEBORGS UNIVERSITET1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IKTOS1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
IMS INFORMATION SOLUTIONS MEDICAL RESEARCH LIMITED1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT DE RECHERCHES SERVIER1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT NATIONAL DU CANCER GIP1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
ISTITUTO EUROPEO DI ONCOLOGIA1
ITASUOMEN YLIOPISTO1
JDRF INTERNATIONAL1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET REGENSBURG1
LA SANTE EPIDEMIOLOGIE EVALUATION ET RECHERCHE LASER1
LIPOTYPE1
LOODSE1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK SHARP & DOHME CORP1
MILTENYI BIOTEC BV & CO KG1
MINDBYTES1
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NOVO NORDISK1
NV SAS INSTITUTE1
NVIDIA SWITZERLAND1
ORION OYJ1
OSPEDALE PEDIATRICO BAMBINO GESU1
OWKIN FRANCE1
PFIZER LIMITED1
PINSENT MASONS LLP1
SANOFIAVENTIS1
SANOFIAVENTIS DEUTSCHLAND1
SIB INSTITUT SUISSE DE BIOINFORMATIQUE1
STEINBEISSER PROJECT MANAGEMENT UG1
STICHTING EUROPEAN UROLOGICAL FOUNDATION1
STICHTING KATHOLIEKE UNIVERSITEIT1
SUBSTRA1
TCURX1
TECHNISCHE UNIVERSITAET MUENCHEN1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE ECANCER GLOBAL FOUNDATION1
THE HYVE BV1
THE REGENTS OF THE UNIVERSITY OF MICHIGAN1
Constancy:

Total number of partners:154

Partner loyalty:
Frequent Partner: (> 2 projects): 13
Rare Partner: 141

Frequent / Rare Partner Ratio: 0.09

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18527
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00035
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum